LON:DNL - Diurnal Group Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Diurnal Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 31 +0.50 (+1.64 %) (As of 04/1/2020 04:00 PM ET) Add Compare Today's Range 29Now: GBX 31▼ 31.5050-Day Range 21MA: GBX 30.26▼ 3652-Week Range 19Now: GBX 31▼ 47Volume125,669 shsAverage Volume7,428 shsMarket Capitalization£26.89 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartEarningsInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Diurnal Group plc operates as a specialty pharma company. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients, as well as adrenal insufficiency. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.Read More Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolLON:DNL Previous Symbol CUSIPN/A CIKN/A Webhttp://www.diurnal.co.uk/ Phone+44-29-20682069Debt Debt-to-Equity Ratio0.77 Current Ratio4.46 Quick Ratio3.80Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£2.01 million Price / Sales13.41 Cash FlowGBX 6.44 per share Price / Cash Flow4.81 Book ValueGBX 8.60 per share Price / Book3.60Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees23 Outstanding Shares86,726,000Market Cap£26.89 million Next Earnings DateN/A OptionableNot Optionable Receive DNL News and Ratings via Email Sign-up to receive the latest news and ratings for DNL and its competitors with MarketBeat's FREE daily newsletter. LSE:DNL Rates by TradingView Diurnal Group (LON:DNL) Frequently Asked Questions How has Diurnal Group's stock been impacted by COVID-19 (Coronavirus)? Diurnal Group's stock was trading at GBX 34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DNL shares have decreased by 8.8% and is now trading at GBX 31. View which stocks have been mosted impacted by Coronavirus. How were Diurnal Group's earnings last quarter? Diurnal Group PLC (LON:DNL) released its quarterly earnings results on Tuesday, February, 11th. The company reported ($4.70) EPS for the quarter. View Diurnal Group's earnings history. Has Diurnal Group been receiving favorable news coverage? News articles about DNL stock have trended very negative on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Diurnal Group earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutDiurnal Group. Who are some of Diurnal Group's key competitors? Some companies that are related to Diurnal Group include Shield Therapeutics (STX), Green Organic Dutchman (TGOD), Supreme Cannabis (FIRE), Delta 9 Cannabis (NINE), WeedMD (WMD), Althea Group (AGH), MMJ Group (MMJ), Depomed (ASRT), Acerus Pharmaceuticals (ASP), Flowr (FLWR), Biosyent (RX), cbdMD (YCBD), Invion (IVX), Zomedica Pharmaceuticals (ZOM) and Science in Sport (SIS). What other stocks do shareholders of Diurnal Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Diurnal Group investors own include Allena Pharmaceuticals (ALNA), Cerecor (CERC), Spero Therapeutics (SPRO), Abercrombie & Fitch (ANF), Ampliphi Biosciences (APHB), SRC Energy (SRCI), Revolution Lighting Technologies (RVLT), Gem Diamonds (GEMD), Arbutus Biopharma (ABUS) and AcelRx Pharmaceuticals (ACRX). Who are Diurnal Group's key executives? Diurnal Group's management team includes the following people: Dr. Martin Whitaker B.Sc., BSc, Ph.D., CEO & Exec. DirectorMr. Richard Edward Bungay BSc, ACA, CFO,Director & Company Sec. (Age 50)Prof. Richard Ross, Chief Scientific Officer & Exec. DirectorMr. Michael Withe, Commercial DirectorMr. John Porter, Medical Director What is Diurnal Group's stock symbol? Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL." How do I buy shares of Diurnal Group? Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Diurnal Group's stock price today? One share of DNL stock can currently be purchased for approximately GBX 31. How big of a company is Diurnal Group? Diurnal Group has a market capitalization of £26.89 million and generates £2.01 million in revenue each year. Diurnal Group employs 23 workers across the globe. View additional information about Diurnal Group. What is Diurnal Group's official website? The official website for Diurnal Group is http://www.diurnal.co.uk/. How can I contact Diurnal Group? Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069. MarketBeat Community Rating for Diurnal Group (LON DNL)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 197 (Vote Outperform)Underperform Votes: 154 (Vote Underperform)Total Votes: 351MarketBeat's community ratings are surveys of what our community members think about Diurnal Group and other stocks. Vote "Outperform" if you believe DNL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DNL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/1/2020 by MarketBeat.com StaffFeatured Article: Why is the ex-dividend date different from the record date?
